Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled Feb. 6, 2020

Bustamante v. Atrium Medical Corporation

Judge
Andrew Carter
Docket
1:18-cv-08395
Court
U.S. District Court · Southern District of New York
Pages
22
TortMotion to DismissCivil Procedure
In one sentence

In Bustamante v. Atrium Medical Corporation, Judge Carter granted dismissal motions but allowed amendment after finding jurisdictional and pleading defects.

Who this affects

The ruling dismissed MCV from the action for lack of personal jurisdiction and dismissed the plaintiffs’ inadequately pleaded claims against the moving defendants, while allowing the plaintiffs to file an amended complaint.

What happened

In Bustamante v. Atrium Medical Corporation, Asuncion Bustamante and Hilda Gabriel alleged that a hernia mesh implanted during Bustamante’s surgery caused injuries. They sued Atrium Medical Corporation, Maquet Cardiovascular, LLC, Ethicon Inc., and Johnson & Johnson Inc. on product-liability, negligence, warranty, fraud, consumer-fraud, unjust-enrichment, punitive-damages, and loss-of-consortium theories.

The court found that it lacked personal jurisdiction over Maquet Cardiovascular because the complaint did not adequately show that the company was subject to general or specific jurisdiction in New York. The court also found that the complaint did not adequately plead the product-defect, warning, fraud, misrepresentation, consumer-fraud, warranty, or unjust-enrichment claims. The court did not address the punitive-damages and loss-of-consortium claims after dismissing the other claims.

Judge Andrew L. Carter, Jr. granted the defendants’ motions to dismiss and granted the plaintiffs leave to amend their complaint by March 5, 2020.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Bustamante v. Atrium Medical Corporation · No. 1:18-cv-08395
Judge
Andrew Carter
Date
Feb. 6, 2020

Background

Asuncion Bustamante and Hilda Gabriel sued Atrium Medical Corporation, Maquet Cardiovascular, LLC (MCV), Ethicon Inc., and Johnson & Johnson Inc. The plaintiffs alleged that Atrium’s ProLite Mesh, implanted during Bustamante’s April 21, 2016 hernia-repair surgery, caused stomach pain, difficulty walking, limited range of motion, and other injuries. The amended complaint asserted strict-liability claims for design defect, manufacturing defect, and failure to warn; negligence; breach of express and implied warranties; fraudulent and negligent misrepresentation; unjust enrichment; consumer fraud; punitive damages; and loss of consortium.

Atrium and MCV moved to dismiss. The opinion treated the factual allegations in the amended complaint as true for purposes of the motions.

Personal Jurisdiction Over MCV

The court first considered whether it could exercise personal jurisdiction—the court’s authority over a defendant—over MCV. The plaintiffs alleged that MCV was organized under New Jersey law and had its principal place of business in New Jersey. The court therefore found that MCV was not “at home” in New York for purposes of general jurisdiction. It also rejected the plaintiffs’ argument that MCV’s New York business registration established general jurisdiction.

The plaintiffs argued that MCV was subject to specific jurisdiction because it bought ProLite Mesh products from Atrium and sold them to Maquet Cardiovascular US, LLC, where Bustamante’s devices were purchased. The court found that the amended complaint did not allege those facts and instead relied largely on conclusory allegations that MCV was Atrium’s alter ego, successor, and agent. The court further stated that, even if MCV had been alleged to be part of the distribution chain, the complaint did not allege that MCV targeted New York or had regular or high-volume sales there. The court concluded that the plaintiffs had not established personal jurisdiction over MCV and that MCV had to be dismissed from the action.

Product-Liability and Negligence Claims

The court analyzed the strict-liability and negligence theories together under New York law.

For design defect, the court held that the plaintiffs had not adequately alleged a feasible safer alternative design. The complaint’s statements that safer alternatives existed, including different materials and non-mesh hernia-repair procedures, were conclusory and lacked supporting facts. The court also stated that alleging that the product should not have been used at all was insufficient to plead a feasible alternative design.

For manufacturing defect, the court found that the plaintiffs did not identify a defective component, a deviation from the manufacturing process, improper workmanship, or defective materials. The court also rejected reliance on Bustamante’s injuries as circumstantial evidence of a manufacturing defect because the complaint described those injuries as common consequences or known side effects of hernia surgeries using mesh products.

For failure to warn, the court found that the allegations were largely conclusory. The complaint did not identify the warnings provided with the device or explain specifically how they were inadequate, inaccurate, or unclear. The court stated that the claim therefore had to be dismissed.

Fraud, Misrepresentation, and Consumer-Fraud Claims

The fraudulent-misrepresentation claims failed to satisfy the heightened pleading requirement for fraud. The plaintiffs identified statements from Atrium’s product brochure but did not explain why those statements were fraudulent. Their omission-based fraud allegations also did not adequately allege reliance because the complaint did not explain what information Bustamante or his physician received or whether they relied on it.

The negligent-misrepresentation claims were dismissed because the plaintiffs did not adequately allege false representations or identify what statements Bustamante or his physician relied on. The consumer-fraud claims were also dismissed because the plaintiffs did not plead facts showing that the defendants’ statements were misrepresentations or that Bustamante or his physician relied on them.

Warranty and Unjust-Enrichment Claims

The express-warranty claim was dismissed because general marketing statements that the ProLite Mesh was safe and effective did not identify a specific actionable warranty or promise on which the plaintiffs relied.

The implied-warranty claim was dismissed because the plaintiffs did not adequately allege that the ProLite Mesh was not reasonably fit for its intended purpose. The court stated that Bustamante’s alleged stomach pain and other common consequences of hernia surgery did not establish that the product was unsafe for its intended use.

The unjust-enrichment claim was dismissed because the plaintiffs did not plausibly allege that the product was defective or that the sale was induced by misrepresentations or omissions, leaving no equitable basis for restitution.

Punitive Damages and Loss of Consortium

The court did not reach the defendants’ remaining arguments concerning punitive damages because punitive damages are not an independent claim and the other claims had been dismissed. The court likewise did not address the loss-of-consortium claims, describing them as derivative of the injured spouse’s underlying injury claim.

Disposition

The court granted Atrium’s and MCV’s motions to dismiss. It also granted the plaintiffs leave to amend because the defendants had not shown bad faith or prejudice. The plaintiffs were ordered to file an amended complaint by March 5, 2020.

The authoritative version

Read the full 22-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.